Clinical trials : coming soon to a physician near you -- Governing human subjects research -- Pursuing contract research -- Coordinating clinical trials -- Monitoring the clinical trials industry -- Recruiting human subjects -- Mobilizing informed consent -- Cultivating pharmaceutical "compliance" -- Changing markets in pharmaceutical research
Summary
Today, more than 75 percent of pharmaceutical drug trials in the United States are being conducted in the private sector. Once the sole province of academic researchers, these important studies are now being outsourced to non-academic physicians. According to Jill A. Fisher, this major change in the way medical research is performed is the outcome of two problems in U.S. health care: decreasing revenue for physicians and decreasing access to treatment for patients. As physicians report diminishing income due to restrictive relationships with insurers, increasing malpractice insurance premiums
Bibliography
Includes bibliographical references (pages 221-244) and index
